Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Dementia01:30

Dementia

108
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
108
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study.

Liver cancer·2026
Same author

Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort.

Journal of hepatology·2026
Same author

Chirality transfer from chiral perovskite to molecular dopants via charge transfer states.

Nature communications·2026
Same author

Resolution of vanishing bile duct syndrome in a patient associated with refractory hodgkin lymphoma following Anti-PD-1 therapy: a case report and literature review.

Annals of hematology·2026
Same author

Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal of gastroenterology and hepatology·2026
Same author

Beyond Curated Knowledge: Structural Protein Embeddings Enhance GNN-Based Personalized Cancer Prognosis.

IEEE journal of biomedical and health informatics·2026

Related Experiment Video

Updated: Jun 17, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Multimodal Attention Network for Dementia Prediction.

Hsinhan Tsai, Ta-Wei Yang, Kai-Hao Ou

    IEEE Journal of Biomedical and Health Informatics
    |August 6, 2024
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a multimodal attention network for dementia (MAND) to predict dementia risk using health insurance data. MAND accurately identifies individuals at high risk, aiding early prevention efforts.

    More Related Videos

    Multi-Modal Home Sleep Monitoring in Older Adults
    07:40

    Multi-Modal Home Sleep Monitoring in Older Adults

    Published on: January 26, 2019

    7.6K
    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
    06:23

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

    Published on: October 13, 2016

    32.2K

    Related Experiment Videos

    Last Updated: Jun 17, 2025

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.0K
    Multi-Modal Home Sleep Monitoring in Older Adults
    07:40

    Multi-Modal Home Sleep Monitoring in Older Adults

    Published on: January 26, 2019

    7.6K
    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
    06:23

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

    Published on: October 13, 2016

    32.2K

    Area of Science:

    • Computational neuroscience
    • Medical informatics
    • Public health

    Background:

    • Early dementia risk identification is vital for prevention and insurance in aging populations.
    • Taiwan's National Health Insurance data presents challenges due to high-dimensional, sparse International Classification of Diseases (ICD) codes.

    Purpose of the Study:

    • To accurately predict future dementia incidence risk using neural networks.
    • To address challenges posed by high-dimensional and sparse ICD code data.

    Main Methods:

    • Developed a multimodal attention network for dementia (MAND) inspired by click-through rate (CTR) prediction models.
    • Incorporated an ICD code embedding layer and multihead self-attention to encode disease interactions.
    • Investigated the applicability of various CTR methods for dementia risk prediction.

    Main Results:

    • MAND achieved an Area Under the Curve (AUC) of 0.9010, outperforming traditional CTR models.
    • Attention score analysis identified key diseases correlated with dementia, aligning with existing research.
    • The model demonstrated high flexibility and interpretability.

    Conclusions:

    • MAND offers an effective and accurate method for predicting dementia risk.
    • The model's insights into disease correlations deepen understanding of dementia.
    • Accurate prediction serves as an early warning system, supporting dementia prevention strategies.